Astria Therapeutics, Inc. — Investor Relations & Filings
Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for allergic and immunologic diseases. The company's mission is to provide life-changing treatments to patients and their families. Its lead product candidate, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein being developed as a potential long-acting, preventative treatment for Hereditary Angioedema (HAE). The company has reported positive initial proof-of-concept results from its ALPHA-STAR Phase 1b/2 clinical trial for STAR-0215. Astria Therapeutics is guided by patient needs to develop differentiated therapeutics that address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject) | 2026-02-09 | English | |
| SCHEDULE 13D/A Filing | 2026-01-28 | English | |
| 4 - ASTRIA THERAPEUTICS, INC. (0001454789) (Filer) | 2026-01-23 | English | |
| 25-NSE Filing | 2026-01-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 29885992 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29886031 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 18466762 | SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject) | 2026-02-09 | English | ||
| 29886027 | SCHEDULE 13D/A Filing | 2026-01-28 | English | ||
| 32892086 | 4 - ASTRIA THERAPEUTICS, INC. (0001454789) (Filer) | 2026-01-23 | English | ||
| 29886124 | 25-NSE Filing | 2026-01-23 | English | ||
| 29886077 | 4 Filing | 2026-01-23 | English | ||
| 29886063 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886048 | 4 Filing | 2026-01-23 | English | ||
| 29886039 | 4 Filing | 2026-01-23 | English | ||
| 29886034 | 8-K Filing | 2026-01-23 | English | ||
| 29886022 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886020 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886001 | 4 Filing | 2026-01-23 | English | ||
| 29886000 | S-8 POS Filing | 2026-01-23 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Astria Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33001/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33001 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33001 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33001 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33001}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Astria Therapeutics, Inc. (id: 33001)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.